Friday, 21 Sep 2018

You are here

Mediterranean Diet Reduces Risk of Rheumatoid Arthritis

High adherence to a Mediterranean diet appears to be associated with a lower risk of rheumatoid arthritis (RA), especially in men and those who are seropositive, according to a study published in Arthritis Research & Therapy.

Researchers from the Karolinska Institutet performed a matched, case-controlled study that analyzed the diet of 1,721 patients with incident RA and 3,667 controls. A Mediterranean diet score (0-9) was based on a 124-item food frequency questionnaire.

Overall they found that 24% of RA patients and 28% of controls had high adherence to the Mediterranean diet (score between 6 and 9).

High adherence to a Mediterranean diet reduced the odds of developing RA by 21% (OR 0.79; 95% CI 0.65–0.96) compared to low adherence (score of 0-2).

The RA risk reduction with a Mediterranean diet only applied to men (OR 0.49; 0.33–0.73), and those who were seropositive for rheumatoid factor (RF) (OR 0.69; 95% CI 0.54–0.88) or those with antibodies to citrullinated peptides (ACPA), but not in ACPA-negative RA.  Interestingly, high adherence to a Mediterranean diet did not benefit women (OR 0.94; 95% CI 0.74–1.18), and ACPA or RF-negative RA (OR 0.96; 95% CI 0.68–1.34).

These findings indicate that the Mediterranean diet score was inversely associated with risk of RA, but only in men and those who have seropositive RA. These findings may have implications in those at risk or those deemed to have "pre-clinical RA".

In other studies the Mediterranean diet has been linked with lower risk of mortality, cardiovascular diseases and cancer.  

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Treat-to-Target in RA: No Increase in AEs

Implementing a treat-to-target approach for the care of rheumatoid arthritis (RA) did not result in an increase in adverse events or resource use, a post-hoc analysis of a randomized trial showed.

Early Exposure to Passive Smoke May Up Risk for RA Later in Life

Exposure to second-hand smoke during childhood was associated with an increased risk for developing rheumatoid arthritis (RA) later in life, researchers said.

Tumor Necrosis Factor Inhibitors Do Not Increase the Risk of Cancer Recurrence

There is a large body of data that shows tumor necrosis factor inhibitors (TNFi) use in rheumatoid arthritis (RA) confers the same risk as that seen in RA - meaning there is no increase over and above that incurred by inflammation and RA itself.  There are fewer studies about whether it is safe to use a TNFi in someone with a pre-existing history of cancer.

Cardiovascular Benefits of Maintaining Biologic Therapy

An Australian prospective study of patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) has shown that sustained use of tumour necrosis factor (TNFi) inhibitors or biologics can reduce the risks of cardiovascular events (CVEs).

Maternal RA Increases Offspring Risk of Autoimmune Disorders

A Danish population study suggests that fetal exposure to maternal rheumatoid arthritis results in an increased offspring risk of thyroid disease, epilepsy and RA, compared to children born to mothers without RA.